The Science Behind ROSE-010

Obesity and Weight Maintenance as well as IBS Acute Pain Treatment.

Rose Pharma is committed to advancing ROSE-010 as a pioneering therapy for IBS pain and weight management. With multiple clinical studies completed, ROSE-010 is being developed as a rapid-acting, short-duration GLP-1 therapy. For weight management, its profile offers flexible, patient-controlled mealtime dosing; for IBS pain, convenient on-demand use. Across both indications, ROSE-010 has demonstrated a favorable tolerability profile. Stay tuned for updates on our clinical programs.

Link to: Science – Obesity & Appetite Control

Obesity & Appetite Control

A Novel Approach to Meal-Time Appetite Suppression. ROSE-010 offers a fast-acting, short-duration alternative to long-acting GLP-1 drugs for appetite control and weight management.



Science - Obesity and Weight Maintenance

Link to: Science-Irritable Bowel Syndrome

IBS Acute Pain Treatment: Fast-Acting Relief for IBS Pain

ROSE-010, a novel short-acting GLP-1 receptor agonist, has demonstrated significant pain relief in IBS patients in clinical studies.



Science - IBS Acute Pain Treatment


Pulmonary Delivery of ROSE-010

Preclinical evidence supporting pulmonary delivery and pharmacodynamic activity of ROSE-010 using Technosphere® technology.



Science - Pulmonary Delivery of ROSE-010